Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Breastlink Med Group
Long Beach, California, United States
- Hematology/oncology P.C. Carl & Dorothy Bennet Cancer Center
Stamford, Connecticut, United States
- Lombardi Cancer Center Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- Florida Cancer Institute
Hudson, Florida, United States
- Gulf Coast Oncology Associates
St. Petersburg, Florida, United States
- Palm Beach Cancer Institute
West Palm Beach, Florida, United States
- Gerogia Cancer Specialist
Atlanta, Georgia, United States
- Maine Center for Cancer Medicine and Blood Disorders
Scarborough, Maine, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- University of Pittsburgh Medical Center Magee Womens Hospital
Pittsburgh, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Southwest Regional Cancer Center
Austin, Texas, United States
- Swedish Medical Center Cancer Institute Research
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2004
- Primary completion
- 1 Oct 2008
- Completion
- 1 Oct 2008
- Last update posted
- 25 Nov 2019
- Registered enrollment
- 32
- Registry id
- NCT00093145
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.